313: Biotech layoffs, founder-focused VC, & a big pharma exit
The Readout Loud
Intro
Exploring layoffs in the drug industry impacting scientists, insights from CuriBio founders on supporting entrepreneurs, and BioPharma updates including Pfizer's leadership change and a new side effect of the diabetes drug Ozempic.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
